Actuate Therapeutics Inc

NASDAQ: ACTU · Real-Time Price · USD
8.00
-0.22 (-2.68%)
At close: Aug 15, 2025, 3:59 PM
8.12
1.56%
After-hours: Aug 15, 2025, 04:10 PM EDT

Actuate Therapeutics Inc Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Revenue
n/a n/a n/a
Cost of Revenue
n/a n/a n/a
Gross Profit
n/a n/a n/a
Operating Income
-25.16M -24.97M -20.21M
Interest Income
222.29K 352.67K 27.03K
Pretax Income
-27.28M -24.74M -20.16M
Net Income
-27.29M -24.74M -20.16M
Selling & General & Admin
6.48M 3.27M 3.82M
Research & Development
18.68M 21.71M 16.39M
Other Expenses
n/a n/a n/a
Operating Expenses
25.16M 24.97M 20.21M
Interest Expense
-18.72K 43.64K 16.2K
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
n/a 24.97M 20.21M
Income Tax Expense
800.00 n/a n/a
Shares Outstanding (Basic)
8.37M 15.03M 15.03M
Shares Outstanding (Diluted)
8.37M 15.03M 15.03M
EPS (Basic)
-3.26 -1.65 -1.34
EPS (Diluted)
-3.26 -1.65 -1.34
EBITDA
-25.16M -24.7M -20.14M
EBIT
-27.3M -24.7M -20.14M
Depreciation & Amortization
2.14M 272.85K 63.61K